Triumph Capital Management Ishares Biotechnology ETF Transaction History

Triumph Capital Management

$270 Million
Q4 2024

A detailed history of Triumph Capital Management transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Triumph Capital Management holds 5,047 shares of IBB stock, worth $677,256. This represents 0.25% of its overall portfolio holdings.

Number of Shares

5,047

Previous 4,860 3.85%

Holding current value

$677,256

Previous $707,000 5.66%

% of portfolio

0.25%

Previous 0.27%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$131.21 - $148.85 $24,536 - $27,834	187 Added 3.85%	5,047 $667,000
Q3 2024 Feb 14, 2025	BUY	$135.09 - $149.47 $220,737 - $244,233	1,634 Added 50.65%	4,860 $707,000
Q2 2024 Feb 14, 2025	SELL	$124.64 - $139.96 $68,925 - $77,397	-553 Reduced 14.63%	3,226 $442,000
Q1 2024 Apr 25, 2024	SELL	$132.3 - $140.89 $11,113 - $11,834	-84 Reduced 2.17%	3,779 $518,000
Q4 2023 Feb 05, 2024	SELL	$112.41 - $137.03 $24,730 - $30,146	-220 Reduced 5.39%	3,863 $524,000
Q3 2023 Oct 31, 2023	BUY	$122.27 - $131.47 $4,279 - $4,601	35 Added 0.86%	4,083 $499,000
Q2 2023 Aug 03, 2023	SELL	$125.53 - $133.58 $45,190 - $48,088	-360 Reduced 8.17%	4,048 $513,000
Q1 2023 May 08, 2023	SELL	$121.97 - $137.23 $112,456 - $126,526	-922 Reduced 17.3%	4,408 $569,000
Q4 2022 Jan 31, 2023	SELL	$117.58 - $138.43 $1.5 Million - $1.76 Million	-12,720 Reduced 70.47%	5,330 $699,000
Q3 2022 Nov 01, 2022	SELL	$113.42 - $134.82 $573,905 - $682,189	-5,060 Reduced 21.9%	18,050 $2.11 Million
Q2 2022 Aug 02, 2022	BUY	$105.82 - $134.76 $897,565 - $1.14 Million	8,482 Added 57.98%	23,110 $2.72 Million
Q1 2022 May 03, 2022	BUY	$119.6 - $152.37 $1.75 Million - $2.23 Million	14,628 New	14,628 $1.91 Million

Others Institutions Holding IBB

# of Institutions

1,015

Shares Held

34.3M

Call Options Held

5.4M

Put Options Held

7.26M

View Full List

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

More about IBB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triumph Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Triumph Capital Management with notifications on news.

Account

Triumph Capital Management Ishares Biotechnology ETF Transaction History